Ars Investment Partners, LLC Gilead Sciences, Inc. Transaction History

Ars Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $285,472 - $332,992	-4,400 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $87,408 - $106,560	-1,200 Reduced 21.43%	4,400 $332,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $711 - $835	-10 Reduced 0.18%	5,600 $401,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $404,537 - $479,486	5,610	5,610 $455,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.